Cite
HARVARD Citation
Daniel, S. et al. (2018). A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximab. Journal of medical economics. pp. 724-731. [Online].